Diabetes Reversal and the Subgingival Microbiota
2 other identifiers
observational
102
1 country
2
Brief Summary
This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. Participants will attend a screening and baseline visit prior to bariatric surgery and three post bariatric surgery appointments (3 weeks post, 6 months post and 1 year to 18 months post). Samples collected at each study visit include blood, plaque, and other oral samples. At the last study visit there is an optional dental cleaning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2019
CompletedFirst Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMarch 19, 2026
March 1, 2026
6.3 years
August 12, 2022
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Bacterial composition
as determined by 16s rRNA community profiling
18 months
Secondary Outcomes (2)
Bacterial mRNA profiling
18 months
Gingival inflammation
18 mos.
Study Arms (2)
Diabetic patients
Diabetic patients who plan to undergo bariatric surgery
Normo-glycemic (non-diabetic) patients
Non-diabetic patients who plan to undergo bariatric surgery
Interventions
Blood, plaque, and other oral samples
Eligibility Criteria
The study participants will be men and women, 25-65 years old, with a Body Mass Index (BMI) of ≥35 kg/m2 who are scheduled to undergo bariatric surgery at the University of Pennsylvania or Temple University for treatment of obesity or obesity and type 2 diabetes. The total target enrollment is 130 diabetic and 104 normoglycemic subjects.
You may qualify if:
- Men and women undergoing bariatric surgery who are 25-65 years old.
- BMI \> 35 kg/m2.
- Diabetic subjects: HbA1c\> 6.0% or fasting plasma glucose \>126 mg/dl).
- Normoglycemic subjects: HbA1c\<5.75% or fasting plasma glucose \<100 mg/dl).
- Dental criteria: Minimum of 4 posterior teeth.
- Signed and dated informed consent form.
- Willing to comply with all study procedures and be available for the duration of the study.
You may not qualify if:
- Subjects diagnosed with type 1 diabetes, maturity onset diabetes of the young (MODY), or latent autoimmune diabetes in adults (LADA).
- Women who are considering pregnancy or are currently breastfeeding.
- Individuals with a history of chronic inflammatory or autoimmune diseases or taking medications that affect immune function or affect body weight such as chronic systemic steroids.
- Currently smoke more than 10 cigarettes per day.
- Periodontal treatment within 3 months of bacterial sampling.
- Acute periodontal infection (abscess) within 1 month of bacterial sampling or abscess in teeth or adjacent teeth within 1 month of sampling.
- Treatment with antibiotics within one month of sample collection (except as part of the surgical regimen of prophylactic antibiotic immediately prior to surgery).
- A treatment regimen of steroids within 1 month of sample collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Temple Universitycollaborator
- Ohio State Universitycollaborator
- University of Pennsylvanialead
- National Institute of Dental and Craniofacial Research (NIDCR)collaborator
Study Sites (2)
Temple University
Philadelphia, Pennsylvania, 19104, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Biospecimen
Oral plaque was collected with the use of a microbrush, small paper points and periopaper strips.
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dana Graves, DDS, DMSc
University of Pennsylvania
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2022
First Posted
August 15, 2022
Study Start
March 11, 2019
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
March 19, 2026
Record last verified: 2026-03